Physician profile
Grace Babb
NPI 1326773862
$1,978.74
in general payments reported to CMS, 2019-2025
15 companies · $517 in 2025
The $517 reported for 2025 was more than what 77% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $483 · 2023: $692 · 2024: $286 · 2025: $517.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,496.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,495.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $702.81 | 2022-2025 | In.Pact Admiral, Hawkone |
| Boehringer Ingelheim Pharmaceuticals, INC. | $270.57 | 2023-2025 | Jardiance |
| Scpharmaceuticals INC. | $174.53 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $161.06 | 2023-2025 | Farxiga, Wainua |
| Boston Scientific Corporation | $150.97 | 2023 | Avvigo Guidance System, Comet |
| Janssen Pharmaceuticals, INC | $131.23 | 2022-2023 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $98.98 | 2023-2025 | Lifevest |
| Kestra Medical Technology Services, INC. | $79.22 | 2024 | Assure Wcd |
| E.R. Squibb & Sons, L.L.C. | $75.44 | 2024-2025 | Eliquis, Camzyos |
| Novartis Pharmaceuticals Corporation | $52.20 | 2025 | |
| Abiomed | $22.70 | 2024 | Impella |
| Atricure, INC. | $15.79 | 2024 | |
| Pfizer INC. | $15.71 | 2022 | |
| Amgen INC. | $14.79 | 2024 | |
| Merck Sharp & Dohme LLC | $12.74 | 2023 | Verquvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Babb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.